Fate Therapeutics to Present at Upcoming December Investor Conferences
November 26 2024 - 4:01PM
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage
biopharmaceutical company dedicated to bringing a first-in-class
pipeline of induced pluripotent stem cell (iPSC)-derived cellular
immunotherapies to patients with cancer and autoimmune diseases,
today announced that the Company will participate in the following
upcoming investor conferences:
- Citi’s 2024 Global Healthcare Conference, including a panel
discussion at 2:30 PM ET on Tuesday, December 3, 2024 in Miami,
Florida; and
- Piper Sandler’s 36th Annual Healthcare Conference, including a
panel discussion at 3:00 PM ET and a fireside chat at 4:00 PM ET on
Wednesday, December 4, 2024 in New York, New York.
A live webcast, if recorded, of each presentation can be
accessed under “Events & Presentations” in the Investors
section of the Company’s website at www.fatetherapeutics.com. The
archived webcast will be available on the Company’s website shortly
after the event.
About Fate Therapeutics, Inc.Fate Therapeutics
is a clinical-stage biopharmaceutical company dedicated to bringing
a first-in-class pipeline of induced pluripotent stem cell
(iPSC)-derived cellular immunotherapies to patients with cancer and
autoimmune diseases. Using its proprietary iPSC product platform,
the Company has established a leadership position in creating
multiplexed-engineered master iPSC lines and in the manufacture and
clinical development of off-the-shelf, iPSC-derived cell products.
The Company’s pipeline includes iPSC-derived natural killer (NK)
cell and T-cell product candidates, which are selectively designed,
incorporate novel synthetic controls of cell function, and are
intended to deliver multiple therapeutic mechanisms to patients.
Fate Therapeutics is headquartered in San Diego, CA. For more
information, please visit www.fatetherapeutics.com.
Contact:Christina TartagliaPrecision
AQ212.362.1200christina.tartaglia@precisionaq.com
Fate Therapeutics (NASDAQ:FATE)
Historical Stock Chart
From Nov 2024 to Dec 2024
Fate Therapeutics (NASDAQ:FATE)
Historical Stock Chart
From Dec 2023 to Dec 2024